STOCK TITAN

TITAN MEDICAL INC ORD - TMDIF STOCK NEWS

Welcome to our dedicated news page for TITAN MEDICAL ORD (Ticker: TMDIF), a resource for investors and traders seeking the latest updates and insights on TITAN MEDICAL ORD.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TITAN MEDICAL ORD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TITAN MEDICAL ORD's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
management
-
Rhea-AI Summary
Titan Medical Inc. (TSX: TMD; OTC: TMDIF) announces financial results for the three and six months ended June 30, 2023, including IP licensing transactions, strategic business transition, executive leadership changes, and improved financial position.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Titan Medical Inc. has entered into a license agreement with Intuitive Surgical, granting them a non-exclusive license to Titan's intellectual property. Titan will receive an upfront payment of US$7.5 million. Titan retains ownership of the licensed IP and the right to develop and license it to other third parties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
TITAN MEDICAL INC ORD

OTC:TMDIF

TMDIF Rankings

TMDIF Stock Data

5.70M
113.51M
0.42%
0.37%
1.33%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Toronto

About TMDIF

titan medical inc. is a canadian public company (tsx venture:tmd)(otcqx:titxf) focused on the design, development and commercialization of new robotic surgical technologies. for more information on titan medical inc. please visit www.titanmedicalinc.com.